ScienceCoimbra
How does the drug that doubles the lifespan of people with advanced pancreatic cancer recently approved in the US work in the body?
oglobo27 August 2026 at 03:02
The FDA approved a new drug, daraxonrasib (marketed as Rasonque), manufactured by Revolution Medicines, for the treatment of advanced pancreatic cancer. This is the first treatment of its kind, administered in two daily tablets, that substantially extends the lives of patients with metastatic disease who have already tried chemotherapy. Although it is not a cure, the drug represents a significant breakthrough in treating a disease historically considered one of the most desperate in medicine.
Related articles
Science
Giant battery to store renewable energy is under our feet</minimax:tool_call>:
27/08/26, 18:10
Science
Eyes on the sky: last partial lunar eclipse of the year happens this early morning
27/08/26, 17:49




